Quantitative analysis for Invivyd, Inc. (IVVD) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Sell (32.0) (grade D). 26 signals analyzed (23 differentiated alt-data).
IVVD stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-28 | $1.50 | $1.37 | $1.38 |
| 2026-05-08 | $1.53 | $1.43 | $1.50 |
| 2026-05-20 | $1.09 | $1.02 | $1.09 |
| 2026-06-02 | $1.22 | $1.13 | $1.14 |
| 2026-06-12 | $0.88 | $0.73 | $0.77 |
| 2026-06-25 | $0.96 | $0.87 | $0.88 |
| 2026-07-08 | $0.95 | $0.80 | $0.83 |
| 2026-07-20 | $0.77 | $0.68 | $0.69 |
| 2026-07-30 | $0.59 | $0.55 | $0.58 |
| 2026-08-12 | $0.74 | $0.67 | $0.73 |
| 2026-08-24 | $0.97 | $0.91 | $0.94 |
| 2026-09-03 | $0.85 | $0.80 | $0.83 |
How Invivyd, Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| CRDL | Cardiol Therapeutics Inc. | $145M | — |
| GALT | Galectin Therapeutics Inc. | $146M | — |
| ABOS | Acumen Pharmaceuticals, Inc. | $142M | — |
| VXRT | Vaxart, Inc. | $148M | — |
View all Health Care stocks by valuation and signals →
Invivyd, Inc. (IVVD) scores Sell (32.0), and the composite conceals a 85-point disagreement between its dimensions. It is strongest on competitive moat at 87 and analyst consensus at 69, and weakest on technicals at 2. A stock can carry competitive moat that high while technicals sits at 2; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| competitive moat | 87 |
| analyst consensus | 69 |
| technicals | 2 |
StoQuant analyzes 26 signals (23 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Invivyd, Inc. (IVVD): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/IVVD"><img src="https://stoquant.com/badge/IVVD.svg" alt="Invivyd, Inc. (IVVD) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.